Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Info on CCC security interest

Hmmm, i have in mind that a change of ownership requires the approval from the other party, otherwise the Master Agreement is violated. so does a change from tpl to dl need much more?

if tpl remains the owner, and did not fund pds properly, are they then in the position to loose a percentage on their mmp ownership?

anyone interested in finding answers to this szenario?

Share
New Message
Please login to post a reply